Health, pharma and science writer at Reuters. Any opinions are mine.

UPDATE 1-Greece has three to four months of medicine supplies, industry says

reuters.com — By Ben Hirschler LONDON, July 6 (Reuters) - Greece has enough medicine to last three to four months and drugmakers said on Monday that they would continue supplying the country for now, despite increased financial uncertainty after Greeks rejected austerity terms of a bailout.

Drugmakers have promised to keep supplying Greece despite being owed $1.2 billion

businessinsider.com — LONDON (Reuters) - Pharmaceutical companies said on Monday they would continue to supply medicines to Greece for now, despite increased financial uncertainty after Greeks rejected the terms of a rescue package from creditors in a referendum.

Drug companies still supplying Greece after 'No' vote

reuters.com — Drugmakers are owned more than 1.1 billion euros ($1.2 billion) by Greek hospitals and the state-run health insurer, after not being paid since December, but have promised to keep supplying the country on humanitarian grounds. The European Federation of Pharmaceutical Industries and Associations (Efpia), representing 40 drug companies, said it stood by a commitment made last week to ensure supplies continued for the coming month.

Row breaks out over Greek medicine supplies

dailymail.co.uk — LONDON, July 3 (Reuters) - Wholesalers trading medicines across European borders have criticised a suggestion by manufacturers that Greek exports should be restricted to prevent shortages of life-saving drugs in the country. Such trade, which allows traders to buy products in low-cost markets and sell them where prices are higher, is allowed under EU free trade rules.

Row breaks out over Greek medicine supplies

reuters.com — Such trade, which allows traders to buy products in low-cost markets and sell them where prices are higher, is allowed under EU free trade rules. But drugmakers have argued this could suck supplies out of Greece if Athens leaves the euro and prices in euro terms fall sharply.

Row breaks out over Greek medicine supplies

reuters.com — Such trade, which allows traders to buy products in low-cost markets and sell them where prices are higher, is allowed under EU free trade rules. But drugmakers have argued this could suck supplies out of Greece if Athens leaves the euro and prices in euro terms fall sharply.

Superbug threat prompts West to revisit Soviet-era virus therapy

dailymail.co.uk — LONDON, July 2 (Reuters) - Alarmed by rising resistance to antibiotics, the main line of defence against bacterial infections, scientists and governments are taking a fresh look at bacteria-chomping viruses first isolated a century ago from the stools of patients recovering from dysentery.

Superbug threat prompts West to revisit Soviet-era virus therapy

in.reuters.com — Alarmed by rising resistance to antibiotics scientists and governments are taking a fresh look at bacteria-chomping viruses first isolated a century ago from the stools of patients recovering from dysentery. Bacteriophages, which attack bacteria but leave human cells unscathed, are still used in Russia, Georgia and Poland, but fell by the wayside in the West with the mass production of penicillin, the first antibiotic, in the 1940s.

INSIGHT-Superbug threat prompts West to revisit Soviet-era virus therapy

reuters.com — May offer last-resort option against resistant bugs * Multi-centre European clinical trial about to start * EU and U.S. authorities convene bacteriophage meetings By Ben Hirschler LONDON, July 2 (Reuters) - Alarmed by rising resistance to antibiotics, the main line of defence against bacterial infections, scientists and governments are taking a fresh look at bacteria-chomping viruses first isolated a century ago from the stools of patients recovering from dysentery.

Novartis to test new pricing model with heart failure drug

in.reuters.com — BASEL, Switzerland Novartis plans to test a novel pricing model with some customers when it launches its keenly awaited new heart failure drug Entresto, the Swiss company's head of pharmaceuticals said on Tuesday. Entresto, also known as LCZ696, is the first new drug in decades for helping patients whose lives are in danger because their hearts cannot pump blood efficiently.
More Articles →
Jul 06, 2015

RT @MarkJTrev: Unfortunate symbolism: workers dismantle giant #euro symbol outside former #ECB headquarters, for maintenance pic.twitter.com/RrABQPicnt



Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.

Email

For instructions on how to pitch Ben Hirschler, email reutersbenhir@muckrack.com.


Share This Profile